Therapeutic effects and prognostic factors of 125I brachytherapy for pelvic recurrence after early cervical cancer surgery
Abstract To investigate the efficacy of 125I seed implantation in the treatment regimen of pelvic recurrence after early cervical cancer surgery and to analyse prognostic factors. To evaluate efficacy and analyse prognostic factors of 125I seed implantation for pelvic recurrence after early cervical...
Guardado en:
Autores principales: | Rui Wang, Jinhu Zhu, Shu Yang, Xiaoqin Chen, Cairu Gu, Tong Liang, Ling Li, Dan Liu, Yanqing Cao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/11b9d3b6e4854a4386ec7a22e7c8be17 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Qin Jiang, et al.
Publicado: (2021) -
Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi F, et al.
Publicado: (2020) -
Iodine-125 Brachytherapy Prophylaxis after Radiofrequency Ablation Cannot Benefit Patients in High Risk of Locoregional Hepatocellular Carcinoma Recurrence
por: Jian-Fei Tu, et al.
Publicado: (2017) -
Chinese Expert Consensus on Iodine125 Seed Implantation for Recurrent Cervical Cancer in 2021
por: Ping Jiang, et al.
Publicado: (2021) -
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
por: Szymon Piatek, et al.
Publicado: (2021)